CHU Clermont Ferrand / CHU Estaing

Clermont-Ferrand

0 studies enrolling now · 1 studies all time

What they study most

Myelodysplastic Syndromes

Studies at this site

• Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome — Stopped early